FDA Adverse Event Malfunction Summary report: N

LEICA BIOSYSTEMS

MDR report key: 5141826 · Received October 7, 2015

Report

Report Number
3004859032-2015-00001
Event Type
Malfunction
Date Received
October 7, 2015
Date of Event
September 9, 2015
Report Date
October 5, 2015
Manufacturer
LEICA BIOSYSTEMS NEWCASTLE LTD
Product Code
MVU
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

WHEN SERIAL SECTIONS OF (B)(6) SKIN SAMPLE (TISSUE ID (B)(6)) WERE STAINED USING BOTH THE CUSTOMER RETURNED AND RETAINED UNITS OF THE BATCH (PB0780, 30241), NO ISSUES WITH (B)(6) STAINING WERE OBSERVED. BOTH PROBES YIELDED STAINING OF AN APPROPRIATE AND ACCEPTABLE INTENSITY AND PATTERN. NO NON-SPECIFIC OR BACKGROUND STAINING WAS OBSERVED. THE DNA (B)(6) AND DNA (B)(6) CONTROLS ALSO STAINED AS EXPECTED, PROVIDING FURTHER CONFIDENCE OF THE PRESENCE OF (B)(6) CELLS. WHILST THE CUSTOMER USES (B)(6) CONTROL TISSUE, THEY DO NOT USE DNA CONTROLS. THIS WOULD HELP PROVIDE MORE INFORMATION REGARDING THE STAINING PATTERN OF ANY TISSUE USED. NO FURTHER ACTION IS REQUIRED.

Description of Event or Problem · 1

LEICA (B)(4) RECEIVED A COMPLAINT ON (B)(6) 2015 REGARDING A FALSE POSITIVE RESULT OBTAINED WITH A HPV PROBE (PRODUCT CODE PB0780). THE SAMPLES AND ALSO THE NEGATIVE CONTROLS ALL DEMONSTRATED POSITIVE STAINING. THE CUSTOMER RE RAN THE TESTS WITH 2 OTHER VIALS OF PRODUCT (THEREFORE USING 3 SEPARATE VIALS IN TOTAL) AND OBTAINED THE SAME RESULTS. ALL THREE VIALS USED IN TESTING WERE FROM LOT 30241. ON (B)(6) 2015, LEICA (B)(4) RECEIVED INFO THAT TISSUE FROM 1 PT DEMONSTRATED FALSE POSITIVE STAINING. THE PT TISSUE HAS BEEN TESTED 3 TIMES IN TOTAL. THIS TOOK 3 WEEKS. THE DIAGNOSIS WAS THEREFORE DELAYED FOR 3 WEEKS AND WAS FINALLY REPORTED AS NEGATIVE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
664413 LEICA BIOSYSTEMS HPV PROBE (SUBTYPES 6, 11) MVU LEICA BIOSYSTEMS NEWCASTLE LTD 30241

Patients

Seq Age Sex Outcome Treatment
1 UNK Other